Modulators of muscarinic receptors

Details for Australian Patent Application No. 2007284350 (hide)

Owner Vertex Pharmaceuticals Incorporated

Inventors Xu, Jingwang; Davies, Robert J.

Agent Spruson & Ferguson

Pub. Number AU-A-2007284350

PCT Pub. Number WO2008/021545

Priority 60/838,701 18.08.06 US

Filing date 20 August 2007

Wipo publication date 21 February 2008

International Classifications

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/14 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

C07D 487/10 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

C07D 487/20 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

C07D 519/00 (2006.01) Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or

Event Publications

12 March 2009 PCT application entered the National Phase

  PCT publication WO2008/021545 Priority application(s): WO2008/021545

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007284353-Epoxy-containing poly(ester amides) and methods of use

2007284345-Customized lithographic particles